17 September, 2018
Notice of Interim Results
e-therapeutics plc (AIM: ETX), the network-driven computational drug discovery company, will announce its interim results for the half-year ended 31 July 2018 on 4 October 2018.
For further information, please contact:
|
e-therapeutics plc Ray Barlow, Chief Executive Officer Steve Medlicott, Finance Director |
Tel: +44 (0) 1993 883 125
|
|
Numis Securities Limited Michael Meade/Freddie Barnfield (Nominated Adviser) James Black (Corporate Broking) |
Tel: +44 (0) 207 260 1000
|
|
FTI Consulting Simon Conway/Brett Pollard |
Tel: +44 (0) 203 727 1000 |